Hemorrhagic blood failure: Oxygen debt, coagulopathy, and endothelial damage

Journal of Trauma and Acute Care Surgery

Volumn 82, Issue 6, 2017, Pages S41-S49

  White, Nathan J ^a   Ward, Kevin R ^b   Pati, Shibani ^c   Strandenes, Geir ^d   Cap, Andrew P ^e  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^e US ARMY INSTITUTE OF SURGICAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OXYGEN;

BLEEDING; BLEEDING DISORDER; BLOOD; BLOOD CLOTTING DISORDER; BLOOD TRANSFUSION; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM; HEMORRHAGIC SHOCK; HUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; REVIEW; VASCULAR ENDOTHELIUM; BLOOD COMPONENT THERAPY; INJURIES; METABOLISM; PATHOPHYSIOLOGY; PROCEDURES; RESUSCITATION;

BLOOD COAGULATION DISORDERS; BLOOD COMPONENT TRANSFUSION; ENDOTHELIUM, VASCULAR; HUMANS; OXYGEN; RESUSCITATION; SHOCK, HEMORRHAGIC;

EID: 85015974964     PISSN: 21630755     EISSN: 21630763     Source Type: Journal    
DOI: 10.1097/TA.0000000000001436     Document Type: Review

References (100)

1. Murray CJ, Lopez AD. Mortality by cause for eight regions of the world: Global Burden of Disease Study. Lancet. 1997;349:1269-1276.
2. Shackford SR, Mackersie RC, Davis JW, Wolf PL, Hoyt DB. Epidemiology and pathology of traumatic deaths occurring at a level I trauma center in a regionalized system: the importance of secondary brain injury. J Trauma. 1989;29(10):1392-1397.
3. Eastridge BJ, Mabry RL, Seguin P, Cantrell J, Tops T, Uribe P, Mallett O, Zubko T, Oetjen-Gerdes L, Rasmussen TE, et al. Death on the battlefield (2001-2011): implications for the future of combat casualty care. J Trauma Acute Care Surg. 2012;73(6 Suppl 5):S431-S437.
4. Baker SP, Whitfield RA, O'Neill B. Geographic variations in mortality from motor vehicle crashes. N Engl J Med. 1987;316:1384-1387.
5. Scope A, Farkash U, Lynn M, Abargel A, Eldad A. Mortality epidemiology in low-intensity warfare: Israel Defense Forces' experience. Injury. 2001; 32(1):1-3.
6. Brohi K, Singh J, Heron M, Coats T. Acute traumatic coagulopathy. J Trauma. 2003;54(6):1127-1130.
7. Hess JR, Brohi K, Dutton RP, Hauser CJ, Holcomb JB, Kluger Y, Mackway-Jones K, Parr MJ, Rizoli SB, Yukioka T, et al. The coagulopathy of trauma: a review of mechanisms. J Trauma. 2008;65(4):748-754.
8. Maegele M, Lefering R, Yucel N, Tjardes T, Rixen D, Paffrath T, Simanski C, Neugebauer E, Bouillon B, AG Polytrauma of the German Trauma Society (DGU). Early coagulopathy in multiple injury: an analysis from the German Trauma Registry on 8724 patients. Injury. 2007;38(3):298-304.
9. van Helmond N, Johnson BD, Curry TB, Cap AP, Convertino VA, Joyner MJ. Coagulation changes during lower body negative pressure and blood loss in humans. Am J Physiol Heart Circ Physiol. 2015;309(9): H1591-H1597.
10. Reed MJ, Burfield LC. Initial emergency department coagulation profile does not predict survival in ruptured abdominal aortic aneurysm. Eur J Emerg Med. 2013;20(6):397-401.
11. Morrison JJ, Dubose JJ, Rasmussen TE, Midwinter MJ. Military Applica-tion of Tranexamic Acid in Trauma Emergency Resuscitation (MATTERs) Study. Arch Surg. 2012; 147(2): 113-119.
12. Zhao Z, Wang M, Tian Y, Hilton T, Salsbery B, Zhou EZ, Wu X, Thiagarajan P, Boilard E, Li M, et al. Cardiolipin-mediated procoagulant activity of mitochondria contributes to traumatic brain injury-associated coagulopathy in mice. Blood. 2016;127(22):2763-2772.
13. White NJ, Contaifer D Jr, Martin EJ, Newton JC, Mohammed BM, Bostic JL, Brophy GM, Spiess BD, Pusateri AE, Ward KR, et al. Early hemostatic responses to trauma identified with hierarchical clustering analysis. J Thromb Haemost. 2015;13(6):978-988.
14. Carroll RC, Craft RM, Langdon RJ, Clanton CR, Snider CC, Wellons DD, Dakin PA, Lawson CM, Enderson BL, Kurek SJ. Early evaluation of acute traumatic coagulopathy by thrombelastography Transl Res. 2009;154(1): 34-39.
15. Floccard B, Rugeri L, Faure A, Saint Denis M, Boyle EM, Peguet O, Levrat A, Guillaume C, Marcotte G, Vulliez A, et al. Early coagulopathy in trauma patients: an on-scene and hospital admission study. Injury. 2012; 43(1):26-32.
16. Davenport R, Manson J, De'Ath H, Platton S, Coates A, Allard S, Hart D, Pearse R, Pasi KJ, MacCallum P, et al. Functional definition and character-ization of acute traumatic coagulopathy. Crit Care Med. 2011;39(12): 2652-2658.
17. Schöchl H, Frietsch T, Pavelka M, Jámbor C. Hyperfibrinolysis after major trauma: differential diagnosis of lysis patterns and prognostic value of thrombelastometry. J Trauma. 2009;67(1):125-131.
18. Chapman MP, Moore EE, Moore HB, Gonzalez E, Morton AP, Chandler J, Fleming CD, Ghasabyan A, Silliman CC, Banerjee A, et al. The "Death Diamond": rapid thrombelastography identifies lethal hyperfibrinolysis. J Trauma Acute Care Surg. 2015;79(6):925-929.
19. Schwameis M, Schober A, Schörgenhofer C, Sperr WR, Schöchl H, Janata-Schwatczek K, Kürkciyan EI, Sterz F, Jilma B. Asphyxia by drowning induces massive bleeding due to hyperfibrinolytic disseminated intravascular coagulation. Crit Care Med. 2015;43(11):2394-2402.
20. Rixen D, Siegel JH. Bench-to-bedside review: oxygen debt and its metabolic correlates as quantifiers of the severity of hemorrhagic and post-traumatic shock. Crit Care. 2005;9:441-453.
21. Barbee RW, Reynolds PS, Ward KR. Assessing shock resuscitation strate-gies by oxygen debt repayment. Shock. 2010;33:113-122.
22. Siegel JH, Fabian M, Smith JA, Kingston EP, Steele KA, Wells MR. Oxygen debt criteria quantify the effectiveness of early partial resuscitation after hypovolemic hemorrhagic shock. J Trauma. 2003;54:862-880.
23. Chaudry IH, Ohkawa M, Clemens MG, Baue AE. Alterations in electron transport and cellular metabolism with shock and trauma. Prog Clin Biol Res. 1983;111:67-88.
24. Szabó C, Módis K. Pathophysiological roles of peroxynitrite in circulatory shock. Shock. 2010;34(Suppl 1):4-14.
25. Weidinger A, Kozlov AV. Biological activities of reactive oxygen and nitro-gen species: oxidative stress versus signal transduction. Biomolecules. 2015;5(2):472-484.
26. Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M, Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol. 2007;39(1):44-84.
27. Chaudry IH, Clemens MG, Baue AE. Alterations in cell function with ischemia and shock and their correction. Arch Surg. 1981;116(10): 1309-1317.
28. James JH, Luchette FA, McCarter FD, Fischer JE. Lactate is an unreliable indicator of tissue hypoxia in injury or sepsis. Lancet. 1999;354(9177): 505-508.
29. Rael LT, Bar-Or R, Salottolo K, Mains CW, Slone DS, Offner PJ, Bar-Or D. Injury severity and serum amyloid A correlate with plasma oxidation-reduction potential in multi-trauma patients: a retrospective analysis. Scand J Trauma Resusc Emerg Med. 2009;17:57.
30. Johansson PI, Ostrowski SR. Acute coagulopathy of trauma: balancing progressive catecholamine induced endothelial activation and damage by fluid phase anticoagulation. Med Hypotheses. 2010;75(6):564-567.
31. Aird WC. Endothelium and haemostasis. Hamostaseologie. 2015;35(1): 11-16.
32. Holcomb JB, Pati S. Optimal trauma resuscitation with plasma as the primary resuscitative fluid: the surgeon's perspective. Hematology Am Soc Hematol Educ Program. 2013;2013:656-659.
33. Watson JJ, Pati S, Schreiber MA. Plasma transfusion: history, current realities, and novel improvements. Shock. 2016;46(5):468-479.
34. Rahbar E, Cardenas JC, Baimukanova G, Usadi B, Bruhn R, Pati S, Ostrowski SR, Johansson PI, Holcomb JB, Wade CE. Endothelial glycoca-lyx shedding and vascular permeability in severely injured trauma patients. J Transl Med. 2015;13:117.
35. Johansson PI, Henriksen HH, Stensballe J, Gybel-Brask M, Cardenas JC, Baer LA, Cotton BA, Holcomb JB, Wade CE, Ostrowski SR. Traumatic endotheliopathy: a prospective observational study of 424 severely injured patients. Ann Surg. 2017;265(3):597-603.
36. Spronk HM, Borissoff JI, ten Cate H. New insights into modulation of thrombin formation. Curr Atheroscler Rep. 2013;15(11):363.
37. Esmon CT. Inflammation and the activated protein C anticoagulant pathway. Semin Thromb Hemost. 2006;32(Suppl 1):49-60.
38. Thurston G, Rudge JS, Ioffe E, Zhou H, Ross L, Croll SD, Glazer N, Holash J, McDonald DM, Yancopoulos GD. Angiopoietin-1 protects the adult vasculature against plasma leakage. Nat Med. 2000;6(4): 460-463.
39. Tuma M, Canestrini S, Alwahab Z, Marshall J. Trauma and endothelial glycocalyx: the microcirculation helmet? Shock. 2016;46(4):352-357.
40. Crimi E, Taccone FS, Infante T, Scolletta S, Crudele V, Napoli C. Effects of intracellular acidosis on endothelial function: an overview. J Crit Care. 2012;27(2):108-118.
41. Haywood-Watson RJ, Holcomb JB, Gonzalez EA, Peng Z, Pati S, Park PW, Wang W, Zaske AM, Menge T, Kozar RA. Modulation of syndecan-1 shedding after hemorrhagic shock and resuscitation. PLoS One. 2011;6(8): e23530.
42. Kozar RA, Pati S. Syndecan-1 restitution by plasma after hemorrhagic shock. J Trauma Acute Care Surg. 2015;78(6 Suppl 1):S83-S86.
43. Ostrowski SR, Johansson PI. Endothelial glycocalyx degradation induces endogenous heparinization in patients with severe injury and early traumatic coagulopathy. J Trauma Acute Care Surg. 2012;73(1):60-66.
44. Johansson PI, Sørensen AM, Perner A, Welling KL, Wanscher M, Larsen CF, Ostrowski SR. High sCD40L levels early after trauma are associated with enhanced shock, sympathoadrenal activation, tissue and endothelial damage, coagulopathy and mortality. J Thromb Haemost. 2012;10(2): 207-216.
45. Itagaki K, Kaczmarek E, Lee YT, Tang IT, Isal B, Adibnia Y, Sandler N, Grimm MJ, Segal BH, Otterbein LE, et al. Mitochondrial DNA released by trauma induces neutrophil extracellular traps. PLoS One. 2015;10(3): e0120549.
46. Barr JD, Chauhan AK, Schaeffer GV, Hansen JK, Motto DG. Red blood cells mediate the onset of thrombosis in the ferric chloride murine model. Blood. 2013;121(18):3733-3741.
47. Weigandt KM, White N, Chung D, Ellingson E, Wang Y, Fu X, Pozzo DC. Fibrin clot structure and mechanics associated with specific oxidation of methionine residues in fibrinogen. Biophys J. 2012;103(11):2399-2407.
48. White NJ, Wang Y, Fu X, Cardenas JC, Martin EJ, Brophy DF, Wade CE, Wang X, St John AE, Lim EB, Stern SA, et al. Post-translational oxidative modification of fibrinogen is associated with coagulopathy after traumatic injury. Free Radic Biol Med. 2016;96:181-189.
49. Cohen MJ, Call M, Nelson M, Calfee CS, Esmon CT, Brohi K, Pittet JF. Critical role of activated protein C in early coagulopathy and later organ failure, infection and death in trauma patients. Ann Surg. 2012;255: 379-385.
50. Campbell JE, Meledeo MA, Cap AP Comparative response of platelet fV and plasma fV to activated protein C and relevance to a model of acute traumatic coagulopathy. PLoS ONE. 2014;9:e99181. 32.
51. Chandler WL. Procoagulant activity in trauma patients. Am J Clin Pathol. 2010;134(1):90-96.
52. Dunbar NM, Chandler WL. Thrombin generation in trauma patients. Transfusion. 2009;49(12):2652-2660.
53. Cardenas JC, Rahbar E, Pommerening MJ, Baer LA, Matijevic N, Cotton BA, Holcomb JB, Wade CE. Measuring thrombin generation as a tool for predicting hemostatic potential and transfusion requirements following trauma. J Trauma Acute Care Surg. 2014;77(6):839-845.
54. Hayakawa M, Sawamura A, Gando S, Kubota N, Uegaki S, Shimojima H, Sugano M, Ieko M. Disseminated intravascular coagulation at an early phase of trauma is associated with consumption coagulopathy and excessive fibrinolysis both by plasmin and neutrophil elastase. Surgery. 2011;149(2): 221-230.
55. Kaplan AP, Ghebrehiwet B. The plasma bradykinin-forming pathways and its interrelationships with complement. Mol Immunol. 2010;47(13): 2161-2169.
56. Marcos-Contreras OA, Martinez de Lizarrondo S, Bardou I, Orset C, Pruvost M, Anfray A, Frigout Y, Hommet Y, Lebouvier L, Montaner J, et al. Hyperfibrinolysis increases blood-brain barrier permeability by a plasmin-and bradykinin-dependent mechanism. Blood. 2016;128: 2423-2434.
57. Bonnefoy A, Legrand C. Proteolysis of subendothelial adhesive glycopro-teins (fibronectin, thrombospondin, and von Willebrand factor) by plasmin, leukocyte cathepsin G, and elastase. Thromb Res. 2000;98(4):323-332.
58. Hermel M, Dailey W, Hartzer MK. Efficacy of plasmin, microplasmin, and streptokinase-plasmin complex for the in vitro degradation of fibronectin and laminin-implications for vitreoretinal surgery. Curr Eye Res. 2010; 35(5):419-424.
59. Sane DC, Moser TL, Greenberg CS. Limited proteolysis of vitronectin by plasmin destroys heparin binding activity. Thromb Haemost. 1991;66(3): 310-314.
60. Loew D, Perrault C, Morales M, Moog S, Ravanat C, Schuhler S, Arcone R, Pietropaolo C, Cazenave JP, van Dorsselaer A, et al. Proteolysis of the exodomain of recombinant protease-activated receptors: prediction of receptor activation or inactivation by MALDI mass spectrometry. Biochemistry. 2000;39(35): 10812-10822.
61. Hur WS, Mazinani N, Lu XJ, Britton HM, Byrnes JR, Wolberg AS, Kastrup CJ. Coagulation factor XIIIa is inactivated by plasmin. Blood. 2015;126(20):2329-2337.
62. Omar MN, Mann KG. Inactivation of factor Va by plasmin. J Biol Chem. 1987;262:9750-9755.
63. Nogami K, Shima M, Matsumoto T, Nishiya K, Tanaka I, Yoshioka A. Mechanisms of plasmin-catalyzed inactivation of factor VIII: a crucial role for proteolytic cleavage at Arg336 responsible for plasmin-catalyzed factor VIII inactivation. J Biol Chem. 2007;282(8):5287-5295.
64. Chapman MP, Moore EE, Moore HB, Gonzalez E, Gamboni F, Chandler JG, Mitra S, Ghasabyan A, Chin TL, Sauaia A, et al. Overwhelming tPA release, not PAI-1 degradation, is responsible for hyperfibrinolysis in severely injured trauma patients. J Trauma Acute Care Surg. 2016;80(1): 16-23.
65. Cardenas JC, Matijevic N, Baer LA, Holcomb JB, Cotton BA, Wade CE. Elevated tissue plasminogen activator and reduced plasminogen activator inhibitor promote hyperfibrinolysis in trauma patients. Shock. 2014;41(6): 514-521.
66. Raza I, Davenport R, Rourke C, Platton S, Manson J, Spoors C, Khan S, De'Ath HD, Allard S, Hart DP, et al. The incidence and magnitude of fibrinolytic activation in trauma patients. J Thromb Haemost. 2013;11(2): 307-314.
67. Moore HB, Moore EE, Liras IN, Gonzalez E, Harvin JA, Holcomb JB, Sauaia A, Cotton BA. Acute fibrinolysis shutdown after injury occurs frequently and increases mortality: a multicenter evaluation of 2, 540 severely injured patients. J Am Coll Surg. 2016;222(4):347-355.
68. Shakur H, Roberts I, Bautista R, Caballero J, Coats T, Dewan Y, El-Sayed H, Gogichaishvili T, Gupta S, Herrera J, et al. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet. 2010;376(9734):23-32.
69. Cap AP. Plasmin: a driver of hemovascular dysfunction. Blood. 2016;128(20): 2375-2376.
70. Kutcher ME, Redick BJ, McCreery RC, Crane IM, Greenberg MD, Cachola LM, Nelson MF, Cohen MJ. Characterization of platelet dysfunc-tion after trauma. J Trauma Acute Care Surg. 2012;73(1):13-19.
71. Jacoby RC, Owings JT, Holmes J, Battistella FD, Gosselin RC, Paglieroni TG. Platelet activation and function after trauma. J Trauma. 2001;51(4): 639-647.
72. White NJ, Newton JC, Martin EJ, Mohammed BM, Contaifer D Jr, Bostic JL, Brophy GM, Spiess BD, Pusateri AE, Ward KR, et al. Clot formation is associated with fibrinogen and platelet forces in a cohort of severely injured emergency department trauma patients. Shock. 2015;44(Suppl 1):39-44.
73. Spinella PC, Doctor A. Role of transfused red blood cells for shock and coagulopathy within remote damage control resuscitation. Shock. 2014; 41(Suppl 1):30-34.
74. Lacroix J, Hébert PC, Fergusson DA, Tinmouth A, Cook DJ, Marshall JC, Clayton L, McIntyre L, Callum J, Turgeon AF, et al., ABLE Investigators; Canadian Critical Care Trials Group. Age of transfused blood in critically ill adults. N Engl J Med. 2015;372(15):1410-1418.
75. Spann AP, Campbell JE, Fitzgibbon SR, Rodriguez A, Cap AP, Blackbourne LH, Shaqfeh ES. The effect of hematocrit on platelet adhe-sion: experiments and simulations. Biophys J. 2016;111(3):577-588.
76. Hellem AJ, Borchgrevink CF, Ames SB. The role of red cells in haemostasis: the relation between haematocrit, bleeding time and platelet adhesiveness. Br J Haematol. 1961;7:42-50.
77. Emerson CP, Ebert RV. A study of shock in battle casualties: measurements of the blood volume changes occurring in response to therapy. Ann Surg. 1945;122(5):745-772.
78. Kozar RA, Peng Z, Zhang R, Holcomb JB, Pati S, Park P, Ko TC, Paredes A. Plasma restoration of endothelial glycocalyx in a rodent model of hem-orrhagic shock. Anesth Analg. 2011;112(6):1289-1295.
79. Pati S, Wataha K, Menge T, Deng X, Bode A, Holcomb JB, Potter D, Kozar R, Spinella PC, Pati S. Spray-dried plasma and fresh frozen plasma modu-late permeability and inflammation in vitro in vascular endothelial cells. Transfusion. 2013;53(Suppl 1):80S-90S.
80. Cardenas JC, Cap AP, Swartz MD, Huby Mdel P, Baer LA, Matijevic N, Cotton BA, Holcomb JB, Wade CE. Plasma resuscitation promotes coagu-lation homeostasis following shock-induced hypercoagulability. Shock. 2016;45(2):166-173.
81. Johnson JL, Moore EE, Kashuk JL, Banerjee A, Cothren CC, Biffl WL, Sauaia A. Effect of blood products transfusion on the development of postinjury multiple organ failure. Arch Surg. 2010;145(10):973-977.
82. Moore HB, Moore EE, Chapman MP, Gonzalez E, Slaughter AL, Morton AP, D'Alessandro A, Hansen KC, Sauaia A, Banerjee A, et al. Viscoelastic measurements of platelet function, not fibrinogen function, predicts sensitivity to tissue-type plasminogen activator in trauma patients. J Thromb Haemost. 2015;13(10):1878-1887.
83. Moore HB, Moore EE, Gonzalez E, Hansen KC, Dzieciatkowska M, Chapman MP, Sauaia A, West B, Banerjee A, Silliman CC. Hemolysis exacerbates hyperfibrinolysis, whereas platelolysis shuts down fibrinolysis: evolving concepts of the spectrum of fibrinolysis in response to severe injury. Shock. 2015;43(1):39-46.
84. Murphy S, Gardner FH. Effect of storage temperature on maintenance of platelet viability-deleterious effect of refrigerated storage. N Engl J Med. 1969;280:1094-1098.
85. Valeri CR. Circulation and hemostatic effectiveness of platelets stored at 4 C or 22 C: studies in aspirin-treated normal volunteers. Transfusion. 1976; 16(1):20-23.
86. Bynum JA, Meledeo MA, Getz TM, Rodriguez AC, Aden JK, Cap AP, Pidcoke HF. Bioenergetic profiling of platelet mitochondria during storage: 4 °C storage extends platelet mitochondrial function and viability. Transfusion. 2016;56(Suppl 1):S76-S84.
87. Baimukanova G, Miyazawa B, Potter DR, Gibb SL, Keating S, Danesh A, Beyer A, Dayter Y, Bruhn R, Muench MO, et al. The effects of 22 °C and 4 °C storage of platelets on vascular endothelial integrity and function. Transfusion. 2016;56(Suppl 1):S52-S64.
88. Torres Filho IP, Torres LN, Valdez C, Salgado C, Cap AP, Dubick MA. Re-frigerated platelets stored in whole blood up to 5 days adhere to thrombi formed during hemorrhagic hypotension in rats. J Thromb Haemost. 2017;15(1):163-175.
89. Fries D, Martini WZ. Role of fibrinogen in trauma-induced coagulopathy. Br J Anaesth. 2010;105(2):116-121.
90. Morrison JJ, Ross JD, Dubose JJ, Jansen JO, Midwinter MJ, Rasmussen TE. Association of cryoprecipitate and tranexamic acid with improved sur-vival following wartime injury: findings from the MATTERs II Study. JAMA Surg. 2013;148(3):218-225.
91. Curry N, Rourke C, Davenport R, Beer S, Pankhurst L, Deary A, Thomas H, Llewelyn C, Green L, Doughty H, et al. Early cryoprecipitate for major haemorrhage in trauma: a randomised controlled feasibility trial. Br J Anaesth. 2015;115(1):76-83.
92. Rourke C, Curry N, Khan S, Taylor R, Raza I, Davenport R, Stanworth S, Brohi K. Fibrinogen levels during trauma hemorrhage, response to replacement therapy, and association with patient outcomes. J Thromb Haemost. 2012;10(7):1342-1351.
93. Holcomb JB, Fox EE, Zhang X, White N, Wade CE, Cotton BA, del Junco DJ, Bulger EM, Cohen MJ, Schreiber MA, et al., PROMMTT Study Group. Cryoprecipitate use in the PROMMTT study. J Trauma Acute Care Surg. 2013;75(1 Suppl 1):S31-S39.
94. Rahbar E, Cardenas JC, Matijevic N, Del Junco D, Podbielski J, Cohen MJ, Cotton BA, Holcomb JB, Wade CE, Early Whole Blood Investigators. Trauma, time, and transfusions: a longitudinal analysis of coagulation markers in severely injured trauma patients receiving modified whole blood or component blood products. Shock. 2015; 44(5):417-425.
95. Cotton BA, Podbielski J, Camp E, Welch T, del Junco D, Bai Y, Hobbs R, Scroggins J, Hartwell B, Kozar RA, et al., Early Whole Blood Investigators. A randomized controlled pilot trial of modified whole blood versus component therapy in severely injured patients requiring large volume transfusions. Ann Surg. 2013;258(4):527-532.
96. Spinella PC, Perkins JG, Grathwohl KW, Beekley AC, Holcomb JB. Warm fresh whole blood is independently associated with improved survival for patients with combat-related traumatic injuries. J Trauma. 2009; 66(Suppl 4):S69-S76.
97. Hooper TJ, Nadler R, Badloe J, Butler FK, Glassberg E. Implementation and execution of military forward resuscitation programs. Shock. 2014; 41(Suppl 1):90-97.
98. Strandenes G, De Pasquale M, Cap AP, Hervig TA, Kristoffersen EK, Hickey M, Cordova C, Berseus O, Eliassen HS, Fisher L, et al. Emergency whole-blood use in the field: a simplified protocol for collection and transfusion. Shock. 2014;41(Suppl 1):76-83.
99. Strandenes G, Austlid I, Apelseth TO, Hervig TA, Sommerfelt-Pettersen J, Herzig MC, Cap AP, Pidcoke HF, Kristoffersen EK. Coagulation function of stored whole blood is preserved for 14 days in austere conditions: a ROTEM feasibility study during a Norwegian antipiracy mission and comparison to equal ratio reconstituted blood. J Trauma Acute Care Surg. 2015;78(6 Suppl 1):S31-S38.
100. Eliassen HS, Aandstad A, Bjerkvig C, Fosse T, Hervig TA, Pidcoke HF, Strandenes G. Making whole blood available in austere medical environments: donor performance and safety. Transfusion. 2016;56(Suppl 2): S166-S172.